POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...

Please provide your email address to receive an email when new articles are posted on . Subacromial decompression with arthroscopic rotator cuff repair yielded a 21% risk reduction for revision ...

Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site. Posimir ® (bupivacaine solution) is now available for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed patients with shoulder ...

POSIMIR® is now commercially available in the U.S. for the treatment of post-surgical pain in adults following arthroscopic subacromial decompression surgery DURECT recently received an $8 million ...

Decompression surgery does not reduce shoulder pain any more than placebo surgery for people with shoulder impingement - when the tendon rubs and catches in the joint, according to the first ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Surgery should not be performed in almost all patients with a common cause of shoulder pain known as subacromial pain syndrome or SAPS (also called shoulder impingement or rotator cuff disease), say a ...